Rydex Series Trust Biotechnology Fund Investor Class: (MF: RYOIX)
(NASDAQ Mutual Funds) As of Apr 25, 2024 08:00 PM ET
$68.87 USD
-0.97 (-1.39%)
Latest Performance as of Mar 31, 2024
Total Return %* | Percentile Rank Objective | |
---|---|---|
YTD | 0.79 | 94 |
3 months | 0.79 | 94 |
6 months | 13.55 | 86 |
1 Year | 9.30 | 90 |
3 Year | -1.31 | 87 |
5 Year | 4.04 | 91 |
10 Year | 6.42 | 89 |
* Annual for three years and beyond.
Bull Market (9/02 - 10/07) | 93.40 |
Bear Market (10/07 - 2/09) | -26.43 |
Bull Market (2/09 - 3/21) | 595.95 |
Load Adjusted Returns as of Mar 31, 2024
1 Year | 9.30 |
5 Year | 4.04 |
10 Year | 6.42 |
Since Inception | 10.44 |
Quarterly Return
1st Qtr. | 2nd Qtr. | 3rd Qtr. | 4th Qtr. | |
---|---|---|---|---|
2024 | 0.79 | NA | NA | NA |
2023 | -2.19 | 0.10 | -3.84 | 12.65 |
2022 | -9.87 | -10.24 | -2.14 | 9.84 |
2021 | -1.55 | 10.07 | -3.17 | -2.97 |
2020 | -14.62 | 28.27 | 0.46 | 10.96 |
2019 | 18.46 | -3.65 | -8.48 | 19.68 |
Annual Return
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|
% Total Return | 0.79 | 6.05 | -13.05 | 1.80 | 22.09 | 25.01 | -8.97 | 29.73 | -19.50 | 8.80 | 33.45 |
% Total Return Rel to Index | -9.76 | -20.18 | 5.15 | -26.88 | 3.68 | -6.47 | -4.58 | 7.93 | -31.44 | 7.42 | 19.80 |
% Total Return Rel to Peer | -7.41 | 0.29 | -3.63 | -6.88 | 0.81 | -1.67 | -9.10 | 7.61 | -8.72 | 1.38 | 7.77 |
% Perf Quintile vs Peer* | 0.00 | 2.00 | 4.00 | 5.00 | 3.00 | 4.00 | 5.00 | 1.00 | 5.00 | 2.00 | 2.00 |
% Dividends | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
% Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Gains ($) | 0.00 | 0.00 | 0.90 | 15.77 | 6.95 | 3.60 | 9.88 | 4.70 | 0.00 | 1.28 | 3.15 |
Expense Ratio | 0.00 | 1.39 | 1.36 | 1.45 | 1.48 | 1.46 | 1.37 | 1.37 | 1.32 | 1.33 | 1.36 |
* 1 = Top 20%, 5 = Bottom 20%